Profiel
William D.
Welch is Vice President of Development for HemaQuest Pharmaceuticals, Inc. Prior to joining HemaQuest Pharmaceuticals, he was Senior Director of Therapeutic Development for ICOS Corp.
from 2002 to 2007, Therapeutic Group Leader of Oncology for Amgen, Inc. from 1997 to 2002 and Director of Laboratory Operations for MetPath Laboratories.
Dr. Welch founded CRO and Western Medical Clinical Laboratories, Inc. and served as President.
He began his career at the University of Texas Health Science Center as an Assistant Professor in the Department of Pathology.
He has more than 20 years of experience in drug development.
Dr. Welch received a PhD in Microbiology and Immunology from the University of California, Los Angeles.
Eerdere bekende functies van William D. Welch
Bedrijven | Functie | Einde |
---|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01-01-2007 |
AMGEN INC. | Corporate Officer/Principal | 01-01-2002 |
MetPath Laboratories | Corporate Officer/Principal | - |
Opleiding van William D. Welch
University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
MetPath Laboratories |